Initiator Pharma A/S (STO:INIT)
Sweden · Delayed Price · Currency is SEK 2.880
-0.030 (-1.03%)
Feb 5, 2026, 4:53 PM CET
Initiator Pharma Market Cap
Initiator Pharma has a market cap or net worth of 199.2 million as of February 5, 2026. Its market cap has decreased by -49.31% in one year.
Market Cap
199.20M
Enterprise Value
159.92M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.88
Market Cap Chart
Since March 16, 2017, Initiator Pharma's market cap has increased from 50.37M to 199.20M, an increase of 295.49%. That is a compound annual growth rate of 16.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 201.25M | -0.68% |
| Dec 30, 2025 | 202.62M | -47.31% |
| Dec 30, 2024 | 384.53M | -20.69% |
| Dec 29, 2023 | 484.84M | 52.80% |
| Dec 30, 2022 | 317.31M | -10.94% |
| Dec 30, 2021 | 356.31M | 167.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elicera Therapeutics AB | 259.67M |
| Xintela AB | 248.91M |
| Magle Chemoswed Holding AB | 235.40M |
| AlzeCure Pharma AB | 229.25M |
| Xbrane Biopharma AB | 216.36M |
| Medivir AB | 200.78M |
| Karolinska Development AB | 187.70M |
| Isofol Medical AB | 182.02M |